Literature DB >> 17698159

Arenavirus entry occurs through a cholesterol-dependent, non-caveolar, clathrin-mediated endocytic mechanism.

Eric M Vela1, Lihong Zhang, Tonya M Colpitts, Robert A Davey, Judith F Aronson.   

Abstract

Arenaviruses are important causes of viral hemorrhagic fevers in humans. Arenavirus infection of cells occurs via a pH-dependent endocytic route, but detailed studies of entry pathways have not been done. We investigated the role of cell membrane cholesterol, caveolae, and clathrin coated pits in infection by Lassa virus (LASV), which utilizes alpha-dystroglycan (alpha-DG) as a receptor, and Pichindé virus (PICV), which does not. Depletion of cellular cholesterol by treatment with methyl betacyclodextrin (MbetaCD) or nystatin/progesterone inhibited PICV replication and transfer of packaged marker gene by LASV or PICV pseudotyped retroviral particles. In cells lacking caveolae due to silencing of the caveolin-1 gene, no inhibition of PICV infection or LASV pseudotype transduction was observed. However, PICV infection and LASV and PICV pseudotype transduction was inhibited when an Eps15 dominant negative mutant was used to inhibit clathrin-mediated endocytosis. Altogether, the results indicate that diverse arenaviruses have a common requirement for cell membrane cholesterol and clathrin mediated endocytosis in establishing infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17698159      PMCID: PMC2227908          DOI: 10.1016/j.virol.2007.07.014

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  60 in total

Review 1.  Cholesterol, lipid rafts, and disease.

Authors:  Kai Simons; Robert Ehehalt
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

Review 2.  Caveolae: from cell biology to animal physiology.

Authors:  Babak Razani; Scott E Woodman; Michael P Lisanti
Journal:  Pharmacol Rev       Date:  2002-09       Impact factor: 25.468

3.  Dynamic association of human insulin receptor with lipid rafts in cells lacking caveolae.

Authors:  Saara Vainio; Sanna Heino; Jan-Eric Mansson; Pam Fredman; Esa Kuismanen; Outi Vaarala; Elina Ikonen
Journal:  EMBO Rep       Date:  2001-12-19       Impact factor: 8.807

4.  The fusion peptide of Semliki Forest virus associates with sterol-rich membrane domains.

Authors:  Anna Ahn; Don L Gibbons; Margaret Kielian
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 5.  Cell adhesion/recognition and signal transduction through glycosphingolipid microdomain.

Authors:  S I Hakomori
Journal:  Glycoconj J       Date:  2000 Mar-Apr       Impact factor: 2.916

Review 6.  Towards a human Lassa fever vaccine.

Authors:  S P Fisher-Hoch; J B McCormick
Journal:  Rev Med Virol       Date:  2001 Sep-Oct       Impact factor: 6.989

7.  Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus.

Authors:  Susan L Kozak; Jean Michel Heard; David Kabat
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

8.  New World arenavirus clade C, but not clade A and B viruses, utilizes alpha-dystroglycan as its major receptor.

Authors:  Christina F Spiropoulou; Stefan Kunz; Pierre E Rollin; Kevin P Campbell; Michael B A Oldstone
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

9.  Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses.

Authors:  Sina Bavari; Catharine M Bosio; Elizabeth Wiegand; Gordon Ruthel; Amy B Will; Thomas W Geisbert; Michael Hevey; Connie Schmaljohn; Alan Schmaljohn; M Javad Aman
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

10.  Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-dystroglycan.

Authors:  S Kunz; N Sevilla; D B McGavern; K P Campbell; M B Oldstone
Journal:  J Cell Biol       Date:  2001-10-15       Impact factor: 10.539

View more
  31 in total

1.  Sodium hydrogen exchangers contribute to arenavirus cell entry.

Authors:  Masaharu Iwasaki; Nhi Ngo; Juan C de la Torre
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

2.  Cell entry of lymphocytic choriomeningitis virus is restricted in myotubes.

Authors:  Masaharu Iwasaki; Shuzo Urata; Yoshitake Cho; Nhi Ngo; Juan C de la Torre
Journal:  Virology       Date:  2014-05-05       Impact factor: 3.616

Review 3.  Hendra and nipah infection: pathology, models and potential therapies.

Authors:  Frederic Vigant; Benhur Lee
Journal:  Infect Disord Drug Targets       Date:  2011-06

4.  Exploring kinase inhibitors as therapies for human arenavirus infections.

Authors:  Eric M Vela; Gavin C Bowick; Norbert K Herzog; Judith F Aronson
Journal:  Future Virol       Date:  2008       Impact factor: 1.831

Review 5.  Structure-function relationship of the mammarenavirus envelope glycoprotein.

Authors:  Wei Wang; Zheng Zhou; Leike Zhang; Shaobo Wang; Gengfu Xiao
Journal:  Virol Sin       Date:  2016-08-04       Impact factor: 4.327

6.  West Nile virus entry requires cholesterol-rich membrane microdomains and is independent of alphavbeta3 integrin.

Authors:  Guruprasad R Medigeshi; Alec J Hirsch; Daniel N Streblow; Janko Nikolich-Zugich; Jay A Nelson
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

7.  Interaction of silver nanoparticles with Tacaribe virus.

Authors:  Janice L Speshock; Richard C Murdock; Laura K Braydich-Stolle; Amanda M Schrand; Saber M Hussain
Journal:  J Nanobiotechnology       Date:  2010-08-18       Impact factor: 10.435

8.  Assembly of arenavirus envelope glycoprotein GPC in detergent-soluble membrane microdomains.

Authors:  Sudhakar S Agnihothram; Brooke Dancho; Kenneth W Grant; Mark L Grimes; Douglas S Lyles; Jack H Nunberg
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

9.  Nuclear translocation of beta-dystroglycan reveals a distinctive trafficking pattern of autoproteolyzed mucins.

Authors:  Maria Luisa Oppizzi; Armin Akhavan; Manisha Singh; Jimmie E Fata; John L Muschler
Journal:  Traffic       Date:  2008-09-18       Impact factor: 6.215

10.  The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses.

Authors:  Eve-Isabelle Pécheur; Viktoriya Borisevich; Peter Halfmann; John D Morrey; Donald F Smee; Mark Prichard; Chad E Mire; Yoshihiro Kawaoka; Thomas W Geisbert; Stephen J Polyak
Journal:  J Virol       Date:  2016-01-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.